Cliff Asness's ASND Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 1,537 shares of Ascendis Pharma A/S (ASND) worth $351,558, representing 0.00% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Cliff Asness has initiated a new position in ASND, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Ascendis Pharma A/S (ASND) Holding Value Over Time
Track share changes against reported price movement
Quarterly Ascendis Pharma A/S (ASND) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +1,537 | New Buy | 1,537 | $228.73 |
Cliff Asness's Ascendis Pharma A/S Investment FAQs
Cliff Asness first purchased Ascendis Pharma A/S (ASND) in Q1 2026, acquiring 1,537 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Ascendis Pharma A/S (ASND) for 1 quarters since Q1 2026.
Cliff Asness's largest addition to Ascendis Pharma A/S (ASND) was in Q1 2026, adding 1,537 shares worth $351,558.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 1,537 shares of Ascendis Pharma A/S (ASND), valued at approximately $351,558.
As of the Q1 2026 filing, Ascendis Pharma A/S (ASND) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Ascendis Pharma A/S (ASND) was 1,537 shares, as reported at the end of Q1 2026.